[HTML][HTML] Mitochondrial mechanisms by which gasotransmitters (H2S, NO and CO) protect cardiovascular system against hypoxia
I Shemarova, V Nesterov, L Emelyanova… - Frontiers in Bioscience …, 2021 - imrpress.com
Over past few years, there has been a dramatic increase in studying physiological
mechanisms of the activity of various signaling low-molecular molecules that directly or …
mechanisms of the activity of various signaling low-molecular molecules that directly or …
Gaseous signaling molecules in cardiovascular function: from mechanisms to clinical translation
SR Lee, B Nilius, J Han - Reviews of Physiology, Biochemistry and …, 2018 - Springer
Carbon monoxide (CO), hydrogen sulfide (H 2 S), and nitric oxide (NO) constitute
endogenous gaseous molecules produced by specific enzymes. These gases are …
endogenous gaseous molecules produced by specific enzymes. These gases are …
Gas signaling molecules and mitochondrial potassium channels
A Walewska, A Szewczyk, P Koprowski - International journal of …, 2018 - mdpi.com
Recently, gaseous signaling molecules, such as carbon monoxide (CO), nitric oxide (NO),
and hydrogen sulfide (H2S), which were previously considered to be highly toxic, have been …
and hydrogen sulfide (H2S), which were previously considered to be highly toxic, have been …
The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote …
Ischaemic heart disease is one of the leading causes of morbidity and mortality worldwide.
The development of cardioprotective therapeutic agents remains a partly unmet need and a …
The development of cardioprotective therapeutic agents remains a partly unmet need and a …
[PDF][PDF] Mitochondrial contribution to the molecular mechanism of heart acclimatization to chronic hypoxia: role of nitric oxide
T Zaobornyj, GF Gonzales, LB Valdez - Front Biosci, 2007 - article.imrpress.com
Introduction 3. Classical parameters of acclimatization to chronic hypoxia 4. Nitric oxide 4.1.
Role of NO in cardiac function 4.2. NO is an effector of cardioprotection 4.3. NOS isoforms …
Role of NO in cardiac function 4.2. NO is an effector of cardioprotection 4.3. NOS isoforms …
The role of mitochondrial reactive oxygen species, NO and H2S in ischaemia/reperfusion injury and cardioprotection
I Andreadou, R Schulz… - Journal of cellular …, 2020 - Wiley Online Library
Redox signalling in mitochondria plays an important role in myocardial
ischaemia/reperfusion (I/R) injury and in cardioprotection. Reactive oxygen and nitrogen …
ischaemia/reperfusion (I/R) injury and in cardioprotection. Reactive oxygen and nitrogen …
Multidimensional regulation of cardiac mitochondrial potassium channels
Mitochondria play a fundamental role in the energetics of cardiac cells. Moreover,
mitochondria are involved in cardiac ischemia/reperfusion injury by opening the …
mitochondria are involved in cardiac ischemia/reperfusion injury by opening the …
Sensing hypoxia by mitochondria: a unifying hypothesis involving S-nitrosation
V Ullrich, S Schildknecht - Antioxidants & Redox Signaling, 2014 - liebertpub.com
Significance: Sudden hypoxia requires a rapid response in tissues with high energy
demand. Mitochondria are rapid sensors for a lack of oxygen, but no consistent mechanism …
demand. Mitochondria are rapid sensors for a lack of oxygen, but no consistent mechanism …
Advances in the Protective Mechanism of NO, H2S, and H2 in Myocardial Ischemic Injury
W Wang, T Ge, X Chen, Y Mao, Y Zhu - Frontiers in Cardiovascular …, 2020 - frontiersin.org
Myocardial ischemic injury is among the top 10 leading causes of death from cardiovascular
diseases worldwide. Myocardial ischemia is caused mainly by coronary artery occlusion or …
diseases worldwide. Myocardial ischemia is caused mainly by coronary artery occlusion or …
Gasotransmitters and noble gases in cardioprotection: unraveling molecular pathways for future therapeutic strategies
P Pagliaro, NC Weber, S Femminò, G Alloatti… - Basic Research in …, 2024 - Springer
Despite recent progress, ischemic heart disease poses a persistent global challenge, driving
significant morbidity and mortality. The pursuit of therapeutic solutions has led to the …
significant morbidity and mortality. The pursuit of therapeutic solutions has led to the …